Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Morgan Stanley
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $14M | 11M | 1.30 |
| 2024-12-31 | $12M | 11M | 1.06 |
| 2024-09-30 | $17M | 15M | 1.17 |
| 2024-06-30 | $17M | 16M | 1.08 |
| 2024-03-31 | $9.4M | 10M | 0.94 |
| 2023-12-31 | $9.0M | 9.2M | 0.98 |
| 2023-09-30 | $9.9M | 11M | 0.92 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1